The company

The pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications.

Management

Bart. Van den Berg

Bart. van den Berg (MSc)
CEO
Joining the company in June 2004, Mr. van den Berg is former general manager and co-founder of two pharmaceutical contract manufacturing companies. Additionally, he founded VenGen BV, a life sciences start-up management company. He was trained in business economics at Tilburg University, the Netherlands.
Michiel Kregel Michiel Kregel, PhD
Operations Manager
Before joining Diagnoptics in 2013, Mr. Kregel worked as a product manager, a consultant in photonics and in spatial information technology. He has managed technical project teams in various settings, such as fluorescence microscopy and geodesy. He has a PhD in Astrophysics from The University of Groningen, The Netherlands.
   

Scientific Advisory Board

Dr. Andries J. Smit (MD, PhD) Medical Advisor/Founder

Dr. Smit founded DiagnOptics Technologies BV in 2003 and has been the medical director since 2004. He has been the head of the Vascular Unit of the University Medical Center Groningen for more than 15 years and has authored or co-authored over 200 scientific publications. He was trained in internal medicine and is professor in internal medicine and in particular the non-invasive assessment of cardiovascular risk. 

Dr. Ir. Reindert Graaff (PhD) Technical Advisor/Founder

Dr. Graaff founded DiagnOptics Technologies BV in 2003 and has been the technical director since 2004. He works at the University Medical Center of Groningen and University of Groningen and was educated in applied physics, specialising in biomedical optics. He wrote a thesis on tissue optics applied to reflectance pulse oximetry.

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

Contact

Our contact details

Diagnoptics Technologies B.V.
Aarhusweg 4-9
9723 JJ Groningen
The Netherlands

Tel: +31 (0)50 589 0612
Fax: +31 (0)50 589 0613
E-mail: info@diagnoptics.com


Follow us on LinkedIn

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.